Cite
HARVARD Citation
Le Gouill, S. et al. (n.d.). Rituximab maintenance after autologous stem‐cell transplantation in patients with mantle cell lymphoma, final result of the LyMA trial conducted on behalf the LYSA group. Hematological oncology. p. 209. [Online].